NCR2 and cancer: The subsequent interaction of the cell surface PCNA (csPCNA) with NKp44 initiates a potent signaling cascade that is predominantly mediated by immune receptor tyrosine-based inhibitory motifs (ITIMs), which inhibit the killing activity of NK cells against cancer cells [43,53,54,55,56,57,58,59].